Arcadia Biosciences (RKDA) Reports Q4 Revenues Above Estimates

Arcadia Biosciences (NASDAQ: RKDA) reported Q4 revenue for the quarter came in at $1.43 million versus the consensus estimate of $800 thousand.

For earnings history and earnings-related data on Arcadia Biosciences (RKDA) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Sun Communities names Ileana McAlary as general counsel and EVP
• OneMain (OMF) Reiterated at Market Outperform by Citizens on Updated Estimates